We serve Chemical Name:4-[[tert-butyl(dimethyl)silyl]oxymethyl]benzoic acid CAS:104292-83-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![4-[[tert-butyl(dimethyl)silyl]oxymethyl]benzoic acid](https://a.dearchem.com/CAS2/104292-83-3.png)
Chemical Name:4-[[tert-butyl(dimethyl)silyl]oxymethyl]benzoic acid
CAS.NO:104292-83-3
Synonyms:HOOC-Ph-CH2OTBDMS
Molecular Formula:C14H22O3Si
Molecular Weight:266.40800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.53000
Exact Mass:266.13400
LogP:3.90660
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like HOOC-Ph-CH2OTBDMS chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HOOC-Ph-CH2OTBDMS physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HOOC-Ph-CH2OTBDMS Use and application,HOOC-Ph-CH2OTBDMS technical grade,usp/ep/jp grade.
Related News: Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. (1S,2S)-8-acetoxy-9-(tert-butyldimethylsilyloxymethyl)-2,3,5,6,7,8-hexahydro-1,2-(N-methylaziridino)-5-oxo-1H-pyrrolo[1,2-a]indole manufacturers Injectable drug devices such as pens and cartridges accounted for 45% of the company’s sales last year, followed by insulin products with 16%. 5′-Methyl-3,4-diphenylpsoralene suppliers We’ve been in the vaccine space for more than 20 years and the impact of [Covid-19] on our revenue was really minor, says Franco. We’re proud of what we have done, but when you produce tens of millions [of pieces] every day, Covid is just one of several businesses. 3-[(E)-2-(11-Fluoro-dibenzo[c,g]phenanthren-9-yl)-vinyl]-benzoic acid methyl ester vendor & factory The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22.,Moreover, the improved stereoselectivity further enhances product purity by ensuring that only one stereoisomer reacts where a mixture of stereoisomers is present.
